HDA issues statement on FDA enforcement discretion of the DSCSA’s final implementation requirements
The Healthcare Distribution Alliance (HDA) released a statement from president and CEO Chester “Chip” Davis, Jr.
Pharmacy
FDA approving drugs after fewer trials, providing less information to public, OSU studies find
The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just a few years ago, a pair of recent studies from Oregon State University found.
Camber launches generic Zetia
Camber Pharmaceuticals nnounces the addition of ezetimibe tablets, USP to its current portfolio.
CVS Health launches Cordavis
CVS Health has launched Cordavis, a wholly owned subsidiary that will work directly with manufacturers to commercialize and/or co-produce biosimilar products (an FDA approved biologic medication that is highly similar to, and has no clinically meaningful differences from, a biologic medicine already
Walgreens, CVS to acquire Winn-Dixie’s pharmacy business
CVS Pharmacy and Walgreens will acquire the prescription files of Winn-Dixie and Harveys supermarkets in conjunction with the sale of the stores to Aldi.
Cardinal Health honors excellence in retail independent pharmacy at RBC 2023
At this year’s Retail Business Conference (RBC), Cardinal Health brought together more than 4,000 retail independent pharmacies here to celebrate the critical role they play in caring for their communities; demonstrate the power of advocacy and their collective voice; and empower them through educat
Mark Cuban Cost Plus Drug Co. and Drexi partner
Drexi, a cutting-edge pharmacy benefit manager (PBM), and Mark Cuban Cost Plus Drug Co., PBC (Cost Plus Drugs), have teamed up to address one of the most pressing challenges in healthcare today: providing better access to the right drugs at affordable prices.
Mutual Drug meets with Rep. Foushee, pharmacy community about industry priorities
During the past few months, HDA member Mutual Drug has been actively involved in advocacy and supply chain partner discussions to underscore the value of pharmaceutical distributors and to provide perspective on policy issues affecting the supply chain.
Upsher-Smith launches mesalamine extended-release capsules
MAPLE GROVE, Minn. – Upsher-Smith announced the recent launch of mesalamine extended-release capsules, USP 375 mg. The mesalamine capsule market had U.S. sales of approximately $105 million for the 12 months ending June 2023 according to IQVIA.
Hy-Vee opens independent infusion clinic in Chicago
Grocery retailer Hy-Vee, Inc. announces today the grand opening of its newest Hy-Vee Health infusion clinic, located at 1 East Erie Street, Suite 640 in Chicago. This is the second Hy-Vee Health infusion clinic to open and the first to open in the Chicago area. The infusion clinic is referral-based
Wellness Day at Walmart rings in school year
BENTONVILLE, Ark. – More than 4,600 Walmart pharmacies will host Wellness Day events on August 16, offering opportunities for families to prioritize their health ahead of a new school year with free screenings and affordable immunizations.
WE panel examines women’s health and wellness gap
Despite the fact that females comprise 80% to 90% of customers in the retail marketplace, many of their needs are unmet regarding their health and wellness. That was a key point made during a panel discussion presented by WE at the National Association of Chain Drug Stores’ Total Store Expo. Now in
Upsher-Smith launches famotidine for oral suspension
MAPLE GROVE, Minn. – Upsher-Smith has announced the recent launch of famotidine for oral suspension, USP. The famotidine oral suspension market had U.S. sales of approximately $73 million for the 12 months ending June 2023 according to IQVIA.
Walgreens unveils new vaccination and testing offerings
Walgreens is offering in-store vouchers and off-site vaccination clinics through its employer vaccination program, and is rolling out a low-cost, 2 results in 1 test for flu and COVID-19 this fall respiratory virus season.